Categories AlphaGraphs, Earnings, Technology
Earnings: Nvidia (NVDA) Q3 profit drops and misses estimates; revenue down 17%
Nvidia Corporation (NASDAQ: NVDA) Wednesday reported lower revenues and earnings for the third quarter of 2023. The bottom line also fell short of expectations.
The Santa Clara-headquartered graphics chipmaker said its adjusted net income declined to $0.58 per share in the October quarter from $1.17 per share a year earlier. Market watchers had predicted a smaller fall. Net income, including special items, was $680 million or $0.27 per share in the latest quarter, compared to $2.46 billion or $0.97 per share in the third quarter of 2022.
The earnings drop reflects a 17% year-over-year decline in revenues to $5.93 billion. The top line, however, exceeded estimates.
Check this space to read management/analysts’ comments on Nvidia’s Q3 2023 earnings
“During the third quarter of fiscal 2023, we returned $3.75 billion to shareholders in the form of share repurchases and cash dividends, and we returned $9.29 billion in the first nine months of fiscal 2023. As of the end of the third quarter of fiscal 2023, we had $8.28 billion remaining under our share repurchase authorization through December 2023,” said Nvidia’s CFO Colette Kress.
Stocks you may like:
International Business Machines Corp. (IBM) Stock
ACN Earnings: All you need to know about Accenture’s Q2 2023 earnings results
Accenture (NYSE: ACN) reported second quarter 2023 earnings results today. Total revenues increased 5% year-over-year to $15.8 billion. Net income attributable to Accenture plc was $1.52 billion, or $2.39 per
Here’s how FedEx (FDX) plans to soften the impact of volume declines on its business
Shares of FedEx Corporation (NYSE: FDX) stayed green on Wednesday. The stock has gained 26% year-to-date. The company faced a challenging environment in the third quarter of 2023 which took
Walgreens Boots Alliance (WBA) shifts to expansion mode. Will it pay off?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in retail pharmacy, has regularly revised its business model to better align with the transformation the healthcare space is witnessing. Currently,